Skip to content

Drug interactions

Bortezomib + Imipramine

Severity: Minor

Bortezomib and Imipramine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bortezomib is a weak inhibitor of CYP2C19 in vitro, which could slightly raise imipramine levels. A clinically significant change has not been well demonstrated. The tricyclic's effects may be more pronounced in patients with other risk factors.

What this interaction means in plain words

Bortezomib and Imipramine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bortezomib belongs to Oncology; Imipramine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible weak inhibition of CYP2C19-mediated imipramine metabolism by bortezomib.

What to do

No empirical dose change is needed. Watch for anticholinergic, sedative or cardiac effects of imipramine.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bortezomib and Imipramine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bortezomib with Imipramine?

MediHelp rates the interaction as minor. Bortezomib and Imipramine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Bortezomib is a weak inhibitor of CYP2C19 in vitro, which could slightly raise imipramine levels. A clinically significant change has not been well demonstrated. The tricyclic's effects may be more pronounced in patients with other risk factors.

How serious is the interaction between Bortezomib and Imipramine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed. Watch for anticholinergic, sedative or cardiac effects of imipramine.

What other medicines interact with Imipramine?

MediHelp also lists interactions of Imipramine with, for example, Dronedarone, Isocarboxazid, Phenelzine. The full list is on the Imipramine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in